Katamine S, Sugiyama H, Moriuchi R, Miyamoto T, Hino S
Jpn J Cancer Res. 1985 Apr;76(4):245-8.
The immunological cross-reactivity of human T-cell leukemia virus type I (HTLV-I)-related sera with lymphadenopathy virus (LAV) was investigated. The sera tested were obtained from 36 adult T-cell leukemia patients, 182 HTLV-I carriers, and 284 control individuals in Nagasaki. Two test methods were utilized: indirect immunofluorescence on LAV-producing cells and solid-phase radioimmunoassay with lysate of LAV. The results were exclusively negative for the presence of antibody activity against LAV, indicating the absence of cross-reaction and endemy in Nagasaki.
对人类T细胞白血病病毒I型（HTLV-I）相关血清与淋巴结病病毒（LAV）的免疫交叉反应性进行了研究。检测的血清取自长崎的36例成人T细胞白血病患者、182例HTLV-I携带者和284名对照个体。采用了两种检测方法：对产生LAV的细胞进行间接免疫荧光法，以及用LAV裂解物进行固相放射免疫测定。针对LAV的抗体活性检测结果均为阴性，表明长崎不存在交叉反应和地方性流行情况。
